Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in Adult Polyglucosan Body Disease
NCT00947960Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jun 2009
- Primary completion
- Jul 2015
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in adult polyglucosan body disease (APBD), sponsored by Baylor Scott & White Research Institute. Started Jun 2009; status: completed.
02
Drugs
triheptanoin
03
Conditions
adult polyglucosan body disease (APBD)
Beyond the preview
Go deeper on NCT00947960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947960.